Cargando…

Subcortical volumes in cerebral amyloid angiopathy compared with Alzheimer’s disease and controls

BACKGROUND: Previous reports have suggested that patients with cerebral amyloid angiopathy (CAA) may harbor smaller white matter, basal ganglia, and cerebellar volumes compared to age-matched healthy controls (HC) or patients with Alzheimer’s disease (AD). We investigated whether CAA is associated w...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chih-Hao, Khnaijer, Mary Klir, Beaudin, Andrew E., McCreary, Cheryl R., Gee, Myrlene, Saad, Feryal, Frayne, Richard, Ismail, Zahinoor, Pike, G. Bruce, Camicioli, Richard, Smith, Eric E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149850/
https://www.ncbi.nlm.nih.gov/pubmed/37139517
http://dx.doi.org/10.3389/fnins.2023.1139196
_version_ 1785035235288678400
author Chen, Chih-Hao
Khnaijer, Mary Klir
Beaudin, Andrew E.
McCreary, Cheryl R.
Gee, Myrlene
Saad, Feryal
Frayne, Richard
Ismail, Zahinoor
Pike, G. Bruce
Camicioli, Richard
Smith, Eric E.
author_facet Chen, Chih-Hao
Khnaijer, Mary Klir
Beaudin, Andrew E.
McCreary, Cheryl R.
Gee, Myrlene
Saad, Feryal
Frayne, Richard
Ismail, Zahinoor
Pike, G. Bruce
Camicioli, Richard
Smith, Eric E.
author_sort Chen, Chih-Hao
collection PubMed
description BACKGROUND: Previous reports have suggested that patients with cerebral amyloid angiopathy (CAA) may harbor smaller white matter, basal ganglia, and cerebellar volumes compared to age-matched healthy controls (HC) or patients with Alzheimer’s disease (AD). We investigated whether CAA is associated with subcortical atrophy. METHODS: The study was based on the multi-site Functional Assessment of Vascular Reactivity cohort and included 78 probable CAA (diagnosed according to the Boston criteria v2.0), 33 AD, and 70 HC. Cerebral and cerebellar volumes were extracted from brain 3D T1-weighted MRI using FreeSurfer (v6.0). Subcortical volumes, including total white matter, thalamus, basal ganglia, and cerebellum were reported as proportion (%) of estimated total intracranial volume. White matter integrity was quantified by the peak width of skeletonized mean diffusivity. RESULTS: Participants in the CAA group were older (74.0 ± 7.0, female 44%) than the AD (69.7 ± 7.5, female 42%) and HC (68.8 ± 7.8, female 69%) groups. CAA participants had the highest white matter hyperintensity volume and worse white matter integrity of the three groups. After adjusting for age, sex, and study site, CAA participants had smaller putamen volumes (mean differences, −0.024% of intracranial volume; 95% confidence intervals, −0.041% to −0.006%; p = 0.005) than the HCs but not AD participants (−0.003%; −0.024 to 0.018%; p = 0.94). Other subcortical volumes including subcortical white matter, thalamus, caudate, globus pallidus, cerebellar cortex or cerebellar white matter were comparable between all three groups. CONCLUSION: In contrast to prior studies, we did not find substantial atrophy of subcortical volumes in CAA compared to AD or HCs, except for the putamen. Differences between studies may reflect heterogeneity in CAA presenting syndromes or severity.
format Online
Article
Text
id pubmed-10149850
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101498502023-05-02 Subcortical volumes in cerebral amyloid angiopathy compared with Alzheimer’s disease and controls Chen, Chih-Hao Khnaijer, Mary Klir Beaudin, Andrew E. McCreary, Cheryl R. Gee, Myrlene Saad, Feryal Frayne, Richard Ismail, Zahinoor Pike, G. Bruce Camicioli, Richard Smith, Eric E. Front Neurosci Neuroscience BACKGROUND: Previous reports have suggested that patients with cerebral amyloid angiopathy (CAA) may harbor smaller white matter, basal ganglia, and cerebellar volumes compared to age-matched healthy controls (HC) or patients with Alzheimer’s disease (AD). We investigated whether CAA is associated with subcortical atrophy. METHODS: The study was based on the multi-site Functional Assessment of Vascular Reactivity cohort and included 78 probable CAA (diagnosed according to the Boston criteria v2.0), 33 AD, and 70 HC. Cerebral and cerebellar volumes were extracted from brain 3D T1-weighted MRI using FreeSurfer (v6.0). Subcortical volumes, including total white matter, thalamus, basal ganglia, and cerebellum were reported as proportion (%) of estimated total intracranial volume. White matter integrity was quantified by the peak width of skeletonized mean diffusivity. RESULTS: Participants in the CAA group were older (74.0 ± 7.0, female 44%) than the AD (69.7 ± 7.5, female 42%) and HC (68.8 ± 7.8, female 69%) groups. CAA participants had the highest white matter hyperintensity volume and worse white matter integrity of the three groups. After adjusting for age, sex, and study site, CAA participants had smaller putamen volumes (mean differences, −0.024% of intracranial volume; 95% confidence intervals, −0.041% to −0.006%; p = 0.005) than the HCs but not AD participants (−0.003%; −0.024 to 0.018%; p = 0.94). Other subcortical volumes including subcortical white matter, thalamus, caudate, globus pallidus, cerebellar cortex or cerebellar white matter were comparable between all three groups. CONCLUSION: In contrast to prior studies, we did not find substantial atrophy of subcortical volumes in CAA compared to AD or HCs, except for the putamen. Differences between studies may reflect heterogeneity in CAA presenting syndromes or severity. Frontiers Media S.A. 2023-04-17 /pmc/articles/PMC10149850/ /pubmed/37139517 http://dx.doi.org/10.3389/fnins.2023.1139196 Text en Copyright © 2023 Chen, Khnaijer, Beaudin, McCreary, Gee, Saad, Frayne, Ismail, Pike, Camicioli and Smith. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Chen, Chih-Hao
Khnaijer, Mary Klir
Beaudin, Andrew E.
McCreary, Cheryl R.
Gee, Myrlene
Saad, Feryal
Frayne, Richard
Ismail, Zahinoor
Pike, G. Bruce
Camicioli, Richard
Smith, Eric E.
Subcortical volumes in cerebral amyloid angiopathy compared with Alzheimer’s disease and controls
title Subcortical volumes in cerebral amyloid angiopathy compared with Alzheimer’s disease and controls
title_full Subcortical volumes in cerebral amyloid angiopathy compared with Alzheimer’s disease and controls
title_fullStr Subcortical volumes in cerebral amyloid angiopathy compared with Alzheimer’s disease and controls
title_full_unstemmed Subcortical volumes in cerebral amyloid angiopathy compared with Alzheimer’s disease and controls
title_short Subcortical volumes in cerebral amyloid angiopathy compared with Alzheimer’s disease and controls
title_sort subcortical volumes in cerebral amyloid angiopathy compared with alzheimer’s disease and controls
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149850/
https://www.ncbi.nlm.nih.gov/pubmed/37139517
http://dx.doi.org/10.3389/fnins.2023.1139196
work_keys_str_mv AT chenchihhao subcorticalvolumesincerebralamyloidangiopathycomparedwithalzheimersdiseaseandcontrols
AT khnaijermaryklir subcorticalvolumesincerebralamyloidangiopathycomparedwithalzheimersdiseaseandcontrols
AT beaudinandrewe subcorticalvolumesincerebralamyloidangiopathycomparedwithalzheimersdiseaseandcontrols
AT mccrearycherylr subcorticalvolumesincerebralamyloidangiopathycomparedwithalzheimersdiseaseandcontrols
AT geemyrlene subcorticalvolumesincerebralamyloidangiopathycomparedwithalzheimersdiseaseandcontrols
AT saadferyal subcorticalvolumesincerebralamyloidangiopathycomparedwithalzheimersdiseaseandcontrols
AT fraynerichard subcorticalvolumesincerebralamyloidangiopathycomparedwithalzheimersdiseaseandcontrols
AT ismailzahinoor subcorticalvolumesincerebralamyloidangiopathycomparedwithalzheimersdiseaseandcontrols
AT pikegbruce subcorticalvolumesincerebralamyloidangiopathycomparedwithalzheimersdiseaseandcontrols
AT camiciolirichard subcorticalvolumesincerebralamyloidangiopathycomparedwithalzheimersdiseaseandcontrols
AT smitherice subcorticalvolumesincerebralamyloidangiopathycomparedwithalzheimersdiseaseandcontrols